Foot-and-mouth disease virus particles inactivated with binary ethylenimine are efficiently internalized into cultured cells

Vaccine

Volumn 29, Issue 52, 2011, Pages 9655-9662

  Martín Acebes, Miguel A ^a,c   Vázquez Calvo, Ángela ^a   González Magaldi, Mónica ^a   Sobrino, Francisco ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c INIA   (Spain)

Author keywords

Binary ethylenimide; Endocytosis; Endosomes; FMDV; Inactivated vaccine; Integrin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; AZIRIDINE; FOOT AND MOUTH DISEASE VACCINE; INTEGRIN; MONOCLONAL ANTIBODY; NOCODAZOLE; RAB PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPOLYMERIZATION; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOSOME; FLUORESCENCE MICROSCOPY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE;

ANIMALS; AZIRIDINES; CELLS, CULTURED; CRICETINAE; DISINFECTANTS; ENDOCYTOSIS; ENDOSOMES; FOOT-AND-MOUTH DISEASE VIRUS; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; TIME-LAPSE IMAGING; VIRION; VIRUS INTERNALIZATION;

EID: 82555168275     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.031     Document Type: Article

References (60)

1. Grubman M.J., Baxt B. Foot-and-mouth disease. Clin Microbiol Rev 2004, 17(April (2)):465-493.
2. Saiz M., Nunez J.I., Jimenez-Clavero M.A., Baranowski E., Sobrino F. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect/Institut Pasteur 2002, 4(September (11)):1183-1192.
3. Cottam E.M, Wadsworth J., Shaw A.E., Rowlands R.J., Goatley L., Maan S., et al. Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007. PLoS Pathog 2008, 4(April (4)):e1000050.
4. Pluimers F.H., Akkerman A.M., van der Wal P., Dekker A., Bianchi A. Lessons from the foot and mouth disease outbreak in The Netherlands in 2001. Revue scientifique et technique (International Office of Epizootics) 2002, 21(December (3)):711-721.
5. Sobrino F., Domingo E. Foot-and-mouth disease in Europe, FMD is economically the most important disease of farm animals. Its re-emergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade. EMBO Rep 2001, 2(June (6)):459-461.
6. Thompson D., Muriel P., Russell D., Osborne P., Bromley A., Rowland M., et al. Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Revue scientifique et technique (International Office of Epizootics) 2002, 21(December (3)):675-687.
7. Chinsangaram J., Mason P.W., Grubman M.J. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 1998, 16(October (16)):1516-1522.
8. Mason P.W., Piccone M.E., McKenna T.S., Chinsangaram J., Grubman M.J. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997, 227(January (1)):96-102.
9. Niborski V., Li Y., Brennan F., Lane M., Torche A.M., Remond M., et al. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 2006, 24(November (49-50)):7204-7213.
10. Wong H.T., Cheng S.C., Chan E.W., Sheng Z.T., Yan W.Y., Zheng Z.X., et al. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 2000, 278(December (1)):27-35.
11. Cubillos C., de la Torre B.G., Jakab A., Clementi G., Borras E., Barcena J., et al. Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol 2008, 82(July (14)):7223-7230.
12. Taboga O., Tami C., Carrillo E., Nuñez J.I., Rodríguez A., Sáiz J.C., et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 1997, 71(April (4)):2606-2614.
13. Bahnemann H.G. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol 1975, 47(1):47-56.
14. Barteling S.J. Modern inactivated foot-and-mouth disease (FMD) vaccines: historical background and key elements in production and use. Foot and mouth disease: current perspectives 2004, Horizon Bioscience, Norfolk. F. Sobrino, E. Domingo (Eds.).
15. Brown F. Inactivation of viruses by aziridines. Vaccine 2001, 20(November (3-4)):322-327.
16. Barnett P.V., Statham R.J., Vosloo W., Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 2003, 21(July (23)):3240-3248.
17. Guzman E., Taylor G., Charleston B., Ellis S.A. Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination. J Virol 2010, 84(December (23)):12375-12384.
18. McCullough K.C., Sobrino F. Immunology of foot-and-mouth disease. Foot and mouth disease: current perspectives 2004, Horizon Bioscience, Norfolk. F. Sobrino, E. Domingo (Eds.).
19. Isaacson M.K., Juckem L.K., Compton T. Virus entry and innate immune activation. Curr Top Microbiol Immunol 2008, 325:85-100.
20. Berryman S., Clark S., Monaghan P., Jackson T. Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. J Virol 2005, 79(July (13)):8519-8534.
21. Martín-Acebes M.A., González-Magaldi M., Sandvig K., Sobrino F., Armas-Portela R. Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol. Virology 2007, 369(December (1)):105-118.
22. O'Donnell V., LaRocco M., Duque H., Baxt B. Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol 2005, 79(July (13)):8506-8518.
23. Baxt B., Becker Y. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 1990, 4(June (1)):73-83.
24. Burman A., Clark S., Abrescia N.G., Fry E.E., Stuart D.I., Jackson T. Specificity of the VP1 GH loop of foot-and-mouth disease virus for alphav integrins. J Virol 2006, 80(October (19)):9798-9810.
25. Baranowski E., Ruiz-Jarabo C.M., Sevilla N., Andreu D., Beck E., Domingo E. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol 2000, 74(February (4)):1641-1647.
26. Baranowski E., Sevilla N., Verdaguer N., Ruiz-Jarabo C.M., Beck E., Domingo E. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol 1998, 72(August (8)):6362-6372.
27. Sá-Carvalho D., Rieder E., Baxt B., Rodarte R., Tanuri A., Mason P.W. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 1997, 71(July (7)):5115-5123.
28. Martín-Acebes M.A., González-Magaldi M., Vázquez-Calvo A., Armas-Portela R., Sobrino F. Internalization of swine vesicular disease virus into cultured cells: a comparative study with foot-and-mouth disease virus. J Virol 2009, 83(May (9)):4216-4226.
29. Sobrino F., Dávila M., Ortín J., Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 1983, 128(July (2)):310-318.
30. Rosas M.F., Vieira Y.A., Postigo R., Martin-Acebes M.A., Armas-Portela R., Martinez-Salas E., et al. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus. Virology 2008, 380(October (1)):34-45.
31. Martín-Acebes M.A., Rincón V., Armas-Portela R., Mateu M.G., Sobrino F. A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition. J Virol 2010, 84(March (6)):2902-2912.
32. García-Arriaza J., Manrubia S.C., Toja M., Domingo E., Escarmís C. Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol 2004, 78(November (21)):11678-11685.
33. Martin-Acebes M.A., Herrera M., Armas-Portela R., Domingo E., Sobrino F. Cell density-dependent expression of viral antigens during persistence of foot-and-mouth disease virus in cell culture. Virology 2010, 403(July (1)):47-55.
34. Brown T.C., Tran I.C., Backos D.S., Esteban J.A. NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD. Neuron 2005, 45(January (1)):81-94.
35. Mateu M.G., Valero M.L., Andreu D., Domingo E. Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem 1996, 271(May (22)):12814-12819.
36. Nuñez J.I., Molina N., Baranowski E., Domingo E., Clark S., Burman A., et al. Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host. J Virol 2007, 81(August (16)):8497-8506.
37. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., et al. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 1994, 2(February (2)):123-139.
38. Patil P.K., Suryanarayana V., Bist P., Bayry J., Natarajan C. Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies. Vaccine 2002, 20(January (7-8)):1163-1168.
39. Lefrancois L., Lyles D.S. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes. Virology 1982, 121(August (1)):168-174.
40. Gutierrez-Rivas M., Pulido M.R., Baranowski E., Sobrino F., Sáiz M. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context. J Gen Virol 2008, 89(October (Pt 10)):2531-2539.
41. Johns H.L., Berryman S., Monaghan P., Belsham G.J., Jackson T. A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry. J Virol 2009, 83(June (12)):6247-6256.
42. Brandenburg B., Lee L.Y., Lakadamyali M., Rust M.J., Zhuang X., Hogle J.M. Imaging Poliovirus Entry in Live Cells. PLoS Biol 2007, 5(July (7)):e183.
43. Pelkmans L., Kartenbeck J., Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001, 3(May (5)):473-483.
44. Pietiäinen V., Marjomäki V., Upla P., Pelkmans L., Helenius A., Hyypiä T. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 2004, 15(November (11)):4911-4925.
45. van der Schaar H.M., Rust M.J., Waarts B.L., van der Ende-Metselaar H., Kuhn R.J., Wilschut J., et al. Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 2007, 81(November (21)):12019-12028.
46. Lakadamyali M., Rust M.J., Zhuang X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006, 124(March (5)):997-1009.
47. Vonderheit A., Helenius A. Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol 2005, 3(July (7)):e233.
48. Doel T.R. FMD vaccines. Virus Res 2003, 91(January (1)):81-99.
49. Aarthi D., Ananda Rao K., Robinson R., Srinivasan V.A. Validation of binary ethylenimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine. Biologicals 2004, 32(September (3)):153-156.
50. Baxt B., Mason P.W. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology 1995, 207(March (2)):503-509.
51. Harwood L.J., Gerber H., Sobrino F., Summerfield A., McCullough K.C. Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response. J Virol 2008, 82(July (13)):6379-6394.
52. Robinson L., Windsor M., McLaughlin K., Hope J., Jackson T., Charleston B. Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. J Virol 2011, 85(March (5)):2212-2223.
53. Jin H., Xiao C., Zhao G., Du X., Yu Y., Kang Y., et al. Induction of immature dendritic cell apoptosis by foot and mouth disease virus is an integrin receptor mediated event before viral infection. J Cell Biochem 2007, 102(November (4)):980-991.
54. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 2008, 1143(November):1-20.
55. Summerfield A., Guzylack-Piriou L., Harwood L., McCullough K.C. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet Immunol Immunopathol 2009, 128(March (1-3)):205-210.
56. Grubman M.J., Moraes M.P., Diaz-San Segundo F., Pena L., de los Santos T. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol Med Microbiol 2008, 53(June (1)):8-17.
57. Burgdorf S., Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 2008, 20(February (1)):89-95.
58. Saiz J.C., Rodriguez A., Gonzalez M., Alonso F., Sobrino F. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus, Involvement of isolated capsid proteins. J Gen Virol 1992, 73(October (Pt 10)):2601-2607.
59. Garcia-Valcarcel M., Doel T., Collen T., Ryan M., Parkhouse R.M. Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. J Gen Virol 1996, 77(April (Pt 4)):727-735.
60. Guzman E., Taylor G., Charleston B., Skinner M.A., Ellis S.A. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol 2008, 89(March (Pt 3)):667-675.